HEALTH TECHNOLOGY

ZS and Abacus Insights Partner to Bring Innovative Data and Analytics to Health Plans

ZS and Abacus Insights | November 30, 2022 | Read time : 03:00 min

ZS and Abacus Insights

As ZS continues to help health plans evolve and transform, the firm announced an investment in and partnership with Abacus Insights, a healthcare technology leader with a groundbreaking offering in data usability that rapidly accelerates the achievement of key health plan goals including efficiency, equity, health services and member outcomes.

At ZS, we believe the future of healthcare is connected, with providers, health plans, pharma companies and other stakeholders working together. Usable data from Abacus Insights is a key enabler and connecter, and we take seriously our role in helping health plans innovate and excel. Partnerships like this one between ZS and Abacus Insights will be increasingly important in a connected health ecosystem.”

ZS CEO Pratap Khedkar

Abacus Insights offers the capability to consolidate and clean billions of pieces of structured and unstructured data from payers, providers, labs, digital apps and many more sources, providing end users with complete, current and accurate data sets that drive both operational and analytical uses. Through this partnership, health plans working with ZS gain access to usable data and a full suite of analytics and digital tools, unlocking insights from sales to operations to health outcomes and accelerating a path to decisions and actions.

“Abacus Insights is proud to have the support of ZS both as an investor and partner. ZS recognizes that data usability is a game-changer in creating and scaling big performance advances for health plans,” said Minal Patel, Abacus Insights CEO. “Our companies share a common purpose to improve healthcare. Our combined health plan-specific expertise will accelerate our ability to help clients achieve their key transformational goals of better serving their members and leading healthcare change.”

Usable data from Abacus Insights is already powering better quality reporting, more accurate risk adjustment and improved value-based contracting, care and payments. ZS Managing Principal Adam Siskind, who leads the firm’s health plan and provider vertical, said the partnership aims to help unlock use cases that health plans can leverage to fully realize the benefits of their analytics transformations.

“There is no shortage of health plan challenges to solve, and it seems there is never enough capacity to unravel them. Our partnership with Abacus Insights will help our clients access the solutions they need to not only reach their goals but to do so efficiently and with scale,” Siskind said. “At ZS, we are proud to be the leading firm at the intersection of healthcare and analytics, so it only made sense to join forces with Abacus Insights, a company already recognized as the leader in health plan data usability in the U.S. Our combined capabilities allow us to achieve a new level of impact that all of our health plan clients seek—and all of their members deserve.”

About ZS
ZS is a management consulting and technology firm focused on transforming global healthcare and beyond. We leverage our leading-edge analytics, plus the power of data, science and products to help our clients make more intelligent decisions, deliver innovative solutions and improve outcomes for all. Founded in 1983, ZS has more than 12,000 employees in 35 offices worldwide. 

About Abacus Insights
Abacus Insights is a healthcare technology leader with the only data transformation platform and solutions built specifically for health plans. Focused on data usability, Abacus Insights gives payers a new level of control and flexibility with their data by developing accurate, timely, and robust ecosystems that can support analytics and operational use cases. Managing data for 21 million members, Abacus Insights partners with payers to deliver scalable solutions that drive strategic initiatives, control costs, and improve member lives and experiences.

Spotlight

The paradigm shift in the digital clinical trial enterprise is here from an increase in trial adoption to enterprise scale.

Spotlight

The paradigm shift in the digital clinical trial enterprise is here from an increase in trial adoption to enterprise scale.

Related News

HEALTH TECHNOLOGY

Canon strengthens medical business with establishment of Canon Healthcare USA, INC.

Canon Medical Systems USA | November 28, 2022

Canon Inc. announced that the company has decided to establish a new subsidiary, to be named Canon Healthcare USA, INC. By strengthening its presence in the highly influential American medical market, Canon aims to accelerate the growth of its medical business. The Canon group is currently working towards a grand strategic transformation of its business portfolio in order to realize future growth. With the announcement of Phase VI, the latest in the company’s Excellent Global Corporation Plan series of 5-year management programs, Canon’s primary objective is to “thoroughly strengthen business competitiveness.” Under this slogan, Canon is striving to increase its competitiveness in various spheres of the medical industry, including diagnostics such as CT, MRI, diagnostic ultrasound systems, as well as medical component businesses such as X-ray tubes, X-ray detectors and key MRI components. In addition, the company is making strides in the field of healthcare IT and in vitro diagnostics. One of the most pressing challenges for Canon’s medical business has been the need to strengthen its presence in the American medical industry, which is extremely influential on the global market. Canon has decided to consider the greater Cleveland area, a key hub in the country’s medical industry as a candidate location for establishing Canon Healthcare USA, INC. in order to strengthen the company’s competitive presence in the global market. With the establishment of Canon Healthcare USA, INC., Canon will transfer a portion of its marketing operations, incubated at the Global Headquarters over Canon’s long history. These operations will transfer to the Global Marketing Center, to be established in January of 2023, in order to strengthen upstream marketing1. By establishing a network with medical institutions on the front lines of treatment and achieving a greater understanding of the market, Canon will develop and propose products and solutions that address the trends and needs of the medical market. Among such efforts is the commencement of joint research with American medical institutions on the practical application of X-ray CT systems utilizing photon counting detection modules, with the goal of capturing the No.1 share of the global CT market at an early stage. In addition, Canon Medical Systems USA the U.S. subsidiary of Canon Medical Systems Corporation will transfer a portion of its product sales and service operations to Canon Healthcare USA. This will integrate operations with downstream marketing2, thereby enabling the company to focus on increasing its share of medical diagnostic systems in the American market. The Cleveland area, one of the candidate locations, is home to the headquarters and factory of Quality Electrodynamics, LLC which develops and manufactures MRI key components and was welcomed into the Canon Group in 2019. By placing QED under the umbrella of Canon Healthcare USA, Canon will aim to increase coordination between its system and component businesses. Furthermore, Canon Medical will take over the advanced technology research activities that Canon has been conducting with Massachusetts General Hospital and Brigham Women’s Hospital at the Healthcare Optics Research Laboratory in Boston for 10 years, and will promote joint research aimed at commercialization in collaboration with the Global Marketing Center. In addition, Canon is considering the possibility of expanding U.S.-based development, manufacturing and other capabilities, with the goal of further strengthening its business in the country. The establishment of this new company and expansion of business operations is expected to require USD $300 million of investment capital. This investment will empower Canon’s medical business to grow by deepening its understanding of customer and market needs, as well as redouble its efforts in the American market, thereby contributing to the global medical industry.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Memora Health and Perigen Collaborate For maternal and Infant Care Innovations

Memora Health and Perigen | January 09, 2023

Memora Health, one of the leaders in virtual care delivery and managing complex care, teamed up with PeriGen, a pioneer in using AI to make childbirth safer. Memora Health, which has the finest intelligent platform for virtual care delivery and managing complex care, announced a partnership with PeriGen, the market leader in using artificial intelligence (AI) to make childbirth safer. It is the first partnership of its kind, which aims to give health systems a chance to use cutting-edge technology to keep an eye on and interact with obstetrics patients at home during labor and after the baby is born. Hence, this coordinated solution for women's health can be used by all healthcare systems in the country. It is the first collaboration to combine an inpatient labor and delivery solution with a post-discharge monitoring tool for the same patients. As a result, Memora and PeriGen customers' reports improved results significantly. "Health systems offering robust maternal and fetal monitoring that supports new families during labor and throughout their transition home can gain tremendous lifetime loyalty from these investments," said Manav Sevak, Co-Founder and CEO of Memora Health. He further added, "We're excited to partner with PeriGen to offer this innovative solution that can help health systems continue to use their digital assets as a key strategic lever to remain competitive in a challenging market." (Source: PR Newswire) About Perigen Perigen, a company owned by Halma, makes innovative perinatal software solutions that use advanced statistical analysis tools to make care during childbirth more efficient and consistent. The company comprises skilled OB doctors and IT experts. The PeriWatch® platform provides consistent analysis and efficient display of complex data to help people recognize and talk about problems that might happen during labor. With PeriWatch®, doctors and nurses can spend more time directly caring for patients and less time doing manual math and data work. About Memora Health Memora Health helps healthcare organizations digitize and automate care programs, making complex care delivery easier for patients and staff. It creates computerized programs that help guide patients through care episodes. Its strong knowledge of clinical workflows and patient experience allows the creation of coherent digital programs that guide patients through care episodes and automate easy EHR follow-up chores for care teams. The company's digital care programs reduce notifications to care teams by 40%, have an average patient NPS of over 70, and improve engagement and clinical results for many groups.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Masimo and Philips Introduce Masimo W1 Watch As Part of a Global Partnership

Masimo | January 19, 2023

On January 18, 2023, Masimo and Royal Philips announced an extension of their partnership to expand the capabilities for patient monitoring in home telehealth applications. Masimo W1™ advanced health tracking watch will unite with Philips' enterprise patient monitoring ecosystem, advancing telemonitoring and telehealth. Masimo W1 is the first wristwatch to provide continuous, precise pulse oximetry measures and other health-related information. Masimo's secure health data cloud will transmit patient information to Philips' patient monitoring environment thereby, facilitating remote clinician monitoring. Hospital experts will remotely monitor patients' vital signs while they go about their regular lives. Physicians can confidently discharge patients, knowing that Masimo W1 will monitor their vital signs while Philips dashboards will scrutinize their physiological status. It will enable physicians and nurses to detect a patient's deterioration earlier and provide better care. This innovative combination of monitoring and networking technology will offer numerous opportunities, including early discharge initiatives, hospital-at-home programs, and the management of chronic illness. Bilal Muhsin, Chief Operating Officer of Masimo Healthcare, expressed, "Expanding our partnership with Philips in this way is a win-win for patients and clinicians everywhere, and is an important part of our multi-year plan to bring the best of hospital monitoring to the home while continuing to improve access to quality hospital care." (Source – Business Wire) About Masimo Masimo develops and manufactures innovative, non-invasive patient monitoring technologies, including medical devices and sensors. The company is making a measurable difference in the world by saving, extending, and improving the lives of people of all ages. For over 30 years, its innovative medical technologies and non-invasive patient monitoring solutions have solved 'unsolvable' problems. The result is a portfolio of clinically-proven products that lead the way in innovation, performance, and patient safety by giving healthcare providers the information they need to optimize clinical decision-making. Through the Masimo Hospital AutomationTM platform, Masimo connectivity, automation, and telehealth and telemonitoring solutions are improving and automating care delivery both in and out of the hospital.

Read More